FCRN-Dependent nasal administration : a new delivery route for monoclonal antibody therapy in chronic rhinosinusitis with polyps - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Conference Papers Year : 2018

FCRN-Dependent nasal administration : a new delivery route for monoclonal antibody therapy in chronic rhinosinusitis with polyps

No file

Dates and versions

inserm-03934479 , version 1 (11-01-2023)

Identifiers

  • HAL Id : inserm-03934479 , version 1

Cite

Émilie Béquignon, Christine Dhommée, Christelle Angely, Lucie Thomas, Mathieu Bottier, et al.. FCRN-Dependent nasal administration : a new delivery route for monoclonal antibody therapy in chronic rhinosinusitis with polyps. European Rhinologic Society, Apr 2018, Londres (London), United Kingdom. ⟨inserm-03934479⟩
14 View
0 Download

Share

Gmail Facebook X LinkedIn More